Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone antibiotic presented as an intravenous formulation for systemic use. It treats a range of serious bacterial infections, including respiratory, urinary, skin, intra‑abdominal and other severe infections, and is administered under medical supervision.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Levalox is manufactured in accordance with EU GMP guidelines, ensuring batch consistency and safety for clinical use.

Levalox, a fluoroquinolone antibiotic, is used to treat bacterial infections affecting several organ systems.

- Respiratory tract infections: Effective against common bacterial pathogens causing pneumonia, bronchitis and sinusitis. - Urinary tract infections: Provides coverage for Gram‑negative organisms responsible for cystitis and pyelonephritis. - Skin and soft tissue infections: Targets Staphylococcus and Streptococcus species in cellulitis, abscesses and wound infections. - Intra‑abdominal infections: Active against mixed aerobic and anaerobic bacteria in peritonitis and intra‑abdominal sepsis. - Severe bacterial infections requiring IV therapy: Used when oral therapy is insufficient or rapid bactericidal action is needed.

Levalox may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset that may be transient. - Diarrhea: loose stools, often self‑limiting but can cause dehydration. - Headache: transient cranial discomfort, usually resolves without treatment. - Rash: mild skin erythema or itching, typically non‑serious.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles, requiring immediate medical attention. - QT interval prolongation: cardiac rhythm disturbances that may lead to arrhythmia, particularly in patients with pre‑existing heart conditions. - Severe hypersensitivity: anaphylaxis, angioedema, or Stevens‑Johnson syndrome, representing life‑threatening immune reactions.

Before initiating Levalox therapy, clinicians should consider several precautionary measures to minimize risks. - Renal impairment: adjust dosing and monitor renal function closely. - History of tendon disorders: avoid use in patients with prior tendon inflammation or injury. - Cardiac conditions: assess baseline ECG for QT prolongation risk. - Concomitant QT‑prolonging drugs: avoid or monitor combined use. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levalox can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate administration by at least 2 hours. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of central nervous system stimulation and seizures. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Theophylline: levofloxacin can increase serum theophylline levels, risking toxicity. - Corticosteroids: combined use may raise risk of tendon rupture. - Diabetic agents (e.g., insulin, sulfonylureas): possible hypoglycemia; monitor blood glucose.